Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer

Completed · Phase 3

Conditions studied: Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms

In brief

The objective of this study is to assess the safety and efficacy of patupilone compared to pegylated liposomal doxorubicin. Additionally, this study will assess the ability of patupilone to extend the survival time and potential beneficial effects in women who have nonresponsive or recurrent ovarian, primary fallopian, or primary peritoneal cancer.

Key facts

Study ID

NCT00262990

Run by

Novartis Pharmaceuticals

People needed

829

Starts

2005-11-01

Last updated by the study team

2020-12-17

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age or older
• Confirmed diagnosis of ovarian, fallopian or peritoneal cancer
• No more than three chemotherapy regimens
• Most recent regimen must have been platinum based

You may not qualify if…

• Have an unresolved bowel obstruction
• Have had previous chemotherapy within 3 weeks
• Recovering from any surgery for any cause
• Other protocol-defined inclusion/exclusion criteria will apply.

Where it is running

• Northern Arizona Hematology & Oncology Associates — Flagstaff, Arizona, United States
• Mayo Center for Women's Health — Scottsdale, Arizona, United States
• Northern Arizona Hematology & Oncology Associates — Sedona, Arizona, United States
• Genesis Cancer Center — Hot Springs, Arkansas, United States
• University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
• Yanagihara, Ronald H. — Gilroy, California, United States
• California Cancer Care, Inc. — Greenbrae, California, United States
• University of California - San Diego/ Moores Cancer Center — La Jolla, California, United States
• LAC & USC Women's & Children's Hospital — Los Angeles, California, United States
• Gynecologic Oncology associates — Newport Beach, California, United States
• UC Davis Cancer Center — Sacramento, California, United States
• California Pacific Medical Center Research Institute — San Francisco, California, United States
• Anschutz Cancer Pavilion — Aurora, Colorado, United States
• Anschutz Cancer Pavilion - Clinical Investigations Core — Aurora, Colorado, United States
• University Of Colorado Health Sciences Center — Denver, Colorado, United States
• Yale University School of Medicine — New Haven, Connecticut, United States
• Christiana Gynecologic Oncology, LLC — Newark, Delaware, United States
• Washington Hospital Center/Medstar Research Institute — Washington D.C., District of Columbia, United States
• Florida Gynecologic Oncology — Fort Myers, Florida, United States
• Miami Cancer Center at Mercy Hospital — Miami, Florida, United States
• Miami Cancer Center at University Hospital — Miami, Florida, United States
• University of Miami — Miami, Florida, United States
• Mt. Sinai Medical Center — Miami, Florida, United States
• Advanced Medical Specialties — Miami, Florida, United States
• Alaska Cancer Research & Education Center — Anchorage, Alaska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.